BeStock  
Stocks › Biotechnology › ROIV

Roivant Sciences ROIV

US equityMarket cap rank #706Biotechnology
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Sep 2026

Revenue$35.12M+2,135.6% YoY
Operating profit-$268.05M+12.5% YoY
Net profit-$137.21M+17.4% YoY
Diluted EPS-$0.27-58.8% YoY
Free cash flow$594.21M+407.1% YoY
Operating cash flow$594.42M

Revenue, last 8 quarters

$9.0MDec '24$7.6MMar '25$2.2MJun '25$1.6MSep '25$2.0MDec '25$2.5MMar '26$1.4MJun '26$35.1MSep '26

Net profit, last 8 quarters

$118.1MDec '24$-252.4MMar '25$-273.9MJun '25$-166.0MSep '25$-313.7MDec '25$355.7MMar '26$-290.6MJun '26$-137.2MSep '26

Diluted EPS by quarter

0.23Dec '24-0.29Mar '25-0.33Jun '25-0.17Sep '25-0.38Dec '250.28Mar '26-0.26Jun '26-0.27Sep '26

Free cash flow by quarter

$-209.1MDec '24$-173.4MMar '25$-208.4MJun '25$-193.5MSep '25$-191.5MDec '25$-165.1MMar '26$-270.9MJun '26$594.2MSep '26

Annual revenue

$23.8MFY21$55.3MFY22$31.5MFY23$32.7MFY24$29.1MFY25$8.3MFY26

Profitability & balance sheet

Gross margin88.7%
Operating margin-3,234.0%
Net margin-838.2%
Return on equity-8.2%
Return on assets-6.9%
Return on invested capital-10.9%
Current ratio15.56
Liabilities / assets100.0%
Total debt$92.79M

Income statement

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Revenue as Reported $35.12M $1.44M $8.26M $2.52M $2.00M
Total Operating Revenue $35.12M $1.44M $8.26M $2.52M $2.00M
Cost of Revenue $3.35M $284,000.00 $1.29M $320,000.00 $700,000.00
Gross Profit $31.77M $1.16M $6.98M $2.20M $1.30M
Operating Expense $299.82M $367.54M $1.29B $357.20M $340.45M
Selling and Admin Expenses $154.08M $165.53M $610.47M $158.25M $175.07M
Research & Development $145.75M $202.02M $681.81M $198.95M $165.38M
Operating Profit -$268.05M -$366.39M -$1.29B -$355.00M -$339.15M
Net Non-Operating Interest Income (Expense) $41.61M $36.92M $178.11M $41.18M $43.27M
Non-Operating Interest Income $41.61M $36.92M $178.11M $41.18M $43.27M
Other Income (Expense) $60.09M $34.90M $842.62M $767.91M $5.52M
Gain on Sale of Security $60.29M $36.64M $105.05M -$25.92M $21.59M
Special Income (Charges) $0.00 $392,000.00 $781.26M $781.26M $0.00
Other Non-Operating Income (Expenses) -$200,000.00 -$2.13M -$43.69M $12.57M -$16.07M
Pretax Profit -$166.35M -$294.56M -$264.58M $454.10M -$290.37M
Tax -$13.37M -$3.96M $133.33M $98.35M $23.33M
Net Profit -$137.21M -$290.61M -$397.91M $355.74M -$313.70M
Profit from Continuing Operations -$152.97M -$290.61M -$397.91M $355.74M -$313.70M
Net Income from Discontinuous Operations $15.76M – $0.00 $0.00 $0.00
Minority Interests $54.41M -$100.77M -$98.14M $52.75M -$47.81M
Net Income to Parent Company -$191.62M -$189.84M -$299.77M $302.99M -$265.89M
Net Income to Common Stockholders -$191.62M -$189.84M -$299.77M $302.99M -$265.89M
Basic EPS -$0.27 -$0.26 -$0.43 $0.43 -$0.38
Diluted EPS -$0.27 -$0.26 -$0.54 $0.28 -$0.38
-General & Admin Expense – $165.53M $610.47M $158.25M $175.07M
-Less:Other Special Charges – -$392,000.00 -$770.24M – –
-Gain on Sale Of Business – – $11.03M $11.03M $0.00

Balance sheet

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Assets $4.98B $5.31B $5.71B $5.71B $5.23B
Total Current Assets $4.36B $4.74B $5.17B $5.17B $4.66B
Other Current Assets $4.36B $128.37M $105.32M $105.32M $129.91M
Total Non-Current Assets $620.28M $564.41M $541.30M $541.30M $565.48M
Other Non-Current Assets $620.28M $29.59M $40.92M $40.92M $34.56M
Total Liabilities $4.98B $384.62M $416.28M $416.28M $251.14M
Total Current Liabilities $279.91M $283.60M $281.24M $281.24M $151.96M
-Accounts Payable $11.30M $25.08M $18.00M $18.00M $13.29M
Current Accrued Expenses $132.22M $127.92M $118.50M $118.50M $79.88M
-Current Capital Lease Obligation $13.78M $12.38M $11.15M $11.15M $10.44M
Other Current Liabilities $279.91M $3.21M $583,000.00 $583,000.00 $26,000.00
Long Term Debt and Capital Lease Obligation $92.79M $94.77M $96.29M $96.29M $98.50M
-Long Term Capital Lease Obligation $92.79M $94.77M $96.29M $96.29M $98.50M
Stockholders' Equity $4.02B $4.23B $4.53B $4.53B $4.27B
Additional Paid-In Capital $5.19B $5.13B $5.02B $5.02B $4.94B
Retained Earnings -$1.16B -$900.35M -$501.81M -$501.81M -$695.00M
Other Equity Interests $5.18B – – – –
Minority Interests $575.41M $690.60M $765.04M $765.04M $704.97M
Cash and Cash Equivalents & Short-Term Investments – $3.84B $4.29B $4.29B $4.53B
-Cash and Cash Equivalents – $1.25B $1.42B $1.42B $1.48B
-Short Term Investments – $2.59B $2.87B $2.87B $3.05B
Receivables – $771.63M $770.24M $770.24M –
-Other Receivables – $771.63M $770.24M $770.24M –
Net PPE – $90.21M $92.40M $92.40M $97.01M
-Gross PPE – $90.21M $92.40M $92.40M $97.01M
Investments and Advances – $444.62M $407.99M $407.99M $433.91M
Payables – $99.27M $63.69M $63.69M $20.46M
-Total Tax Payable – $74.18M $45.69M $45.69M $7.17M
Short-Term Debt and Capital Lease Obligation – $12.38M $11.15M $11.15M $10.44M
Total Non-Current Liabilities – $101.02M $135.03M $135.03M $99.18M
Long Term Accounts Payable and Other Payables – $0.00 $38.67M $38.67M –
Other Non-Current Liabilities – $6.25M $70,000.00 $70,000.00 $677,000.00
Total Equity – $4.92B $5.29B $5.29B $4.97B
Capital Stock – $0.00 $0.00 $0.00 $0.00
-Common Stock – $0.00 $0.00 $0.00 $0.00
Gains/Losses Not Affecting Retained Earnings – $701,000.00 $4.36M $4.36M $20.61M
Current Deferred Liabilities – – – – $3.05M

Cash flow

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Operating Cash Flow $594.42M -$270.50M -$750.35M -$163.82M -$196.48M
Net cash flow from continuing operations $594.42M -$270.50M -$750.35M -$163.82M -$196.48M
Net Income from Continuing Operations -$137.21M -$290.61M -$397.91M $355.74M -$313.70M
Depreciation & Depletion & Amortization $604,000.00 $600,000.00 $3.35M $638,000.00 $691,000.00
Other Non-Cash Items $5.51M $11.18M $57.81M $25.95M $10.91M
Change in Working Capital $727.19M -$32.70M -$621.80M -$601.08M $9.37M
-Change in Receivables $771.63M -$1.39M -$770.24M – –
-Change in Payables and Accrued Expense -$9.73M -$16.98M $147.79M $164.43M $4.59M
-Change in Other Current Assets -$31.37M -$21.97M $4.04M $11.04M $658,000.00
-Change in Other Current Liabilities -$3.34M $7.64M -$3.39M -$1.28M -$903,000.00
Net cash flow from investing $42.54M $281.26M -$682.33M $173.49M $109.47M
Net Cash Flow from Continuing Investing Activities $42.54M $281.26M -$682.33M $173.49M $109.47M
Net PPE Purchase and Sale -$208,000.00 -$419,000.00 -$8.21M -$1.26M $4.94M
Net Investment Purchase and Sale $23.47M $281.68M -$667.19M $179.17M $107.05M
Financing Cash Flow -$249.21M -$181.51M $134.24M -$68.78M $328.19M
Net Cash Flow from Continuing Financing Activities -$249.21M -$181.51M $134.24M -$68.78M $328.19M
Net Common Stock Issuance -$74.47M -$206.73M -$125.90M -$111.21M $193.61M
Proceeds from Stock Option Exercised $25.42M $76.65M $269.51M $51.19M $119.20M
Net Other Financing Charges -$200.16M -$51.44M -$9.37M -$8.75M $15.39M
Ending Cash Balance $1.65B $1.26B $1.43B $1.43B $1.49B
Net Change in Cash $387.74M -$170.75M -$1.30B -$59.10M $241.18M
Beginning Cash Balance $1.26B $1.43B $2.73B $1.49B $1.25B
Effect of Exchange Rate Changes $1.30M $315,000.00 $3.77M $1.32M $430,000.00
Free Cash Flow $594.21M -$270.92M -$758.56M -$165.08M -$191.55M
Gain/Loss from Continuing Operations – – -$12.00M -$11.66M –
Net Business Purchase and Sale – – -$4.42M -$4.42M $0.00
Net Other Investing Changes – – -$2.52M $0.00 –
Net Issuance Payments Of Debt – – $0.00 $0.00 $0.00
-Change In Other Working Capital – – – – $8.30M

Discussion

No comments yet — be the first to weigh in on ROIV.

Sign in to join the discussion.

Scroll to Top